|
⚲
|
| Keyboard |
| Paul Schimmel | |
|---|---|
| Firm | |
| Address | 5 Laboratory Drive Suite 2150 Durham, NC 27709 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Boragen Inc | 021-357103 | Director | 2.0 M of 2.0 M |
||
| Kindex Pharmaceuticals Inc | 021-339492 | Director | 0.9 M of 2.0 M |
||
| Boragen Inc | 021-333776 | Director | 3.0 M of 4.2 M |
||
| ATYR Pharma Inc | 021-294795 | Director | 45.8 M of 45.8 M |
||
| Boragen Inc | 021-283118 | Director | 10.5 M of 10.5 M |
||
| Tocagen Inc | 021-275725 | Director | 10.9 M of 13.0 M |
||
| Kindex Pharmaceuticals Inc | 021-269780 | Director | 1.1 M of 1.3 M |
||
| ATYR Pharma Inc | 021-237156 | Director | 76.3 M of 76.3 M |
||
| Kindex Pharmaceuticals Inc | 021-213543 | Director | 5.5 M of 10.0 M |
||
| Tocagen Inc | 021-197726 | Director | 46.2 M of 50.4 M |
||
| Abide Therapeutics Inc | 021-168913 | Director | 2.2 M of 2.3 M |
||